Health Topics
What are lung cancer genetic tests?
If you have lung cancer, your health care provider may order genetic tests. These tests look for changes in the genes of the cancer cells in your body. Gene changes are also called gene variants or mutations. There are many types of gene changes that are found in lung cancer. Knowing what type of gene change you have may help your provider to:
- Predict how your lung cancer will develop over time
- Match your cancer to a targeted therapy that's most likely to help you
Targeted therapy uses drugs or other substances that mainly attack specific cancer cells and cause less harm to normal cells. It usually has fewer side effects than chemotherapy or radiation therapy.
There are different types of targeted therapies. Each type is designed to work for cancers with specific gene changes. So, lung cancer genetic tests are important to check if your cancer has a gene change that can be treated with targeted therapy.
There are two main types of lung cancer, small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Most people with lung cancer have NSCLC. The most common lung cancer genetic tests are done for NSCLC. That's because this type of lung cancer is more likely to have gene changes that respond to targeted therapies.
Genes are parts of DNA in your cells that you inherit from your parents. Genes carry information that controls what you look like and how your body works. The gene changes found in lung cancer affect genes that control how fast your cells grow and divide to make new cells. Cells with these changes grow out of control and form cancerous tumors that can spread through your body.
The gene changes in lung cancer usually aren't inherited. That means you can't pass them down to your children. You develop gene changes in certain cells in your lungs after you're born. These changes can happen if you're exposed to substances that cause cancer, such as tobacco smoke, radon gas, or air pollution. Gene changes can also happen if your cells make a mistake when they divide to make new cells.
Other names: Lung cancer targeted gene panel
What are they used for?
Lung cancer genetic testing is most often used to look for gene changes that are often involved in non-small cell lung cancer. The results may help guide treatment choices for targeted therapies.
There are many types of gene changes that can be involved in NSCLC. And researchers are still learning about more.
Lung cancer genetic tests may check a single gene or several genes may be checked in one test.
Why do I need a lung cancer genetic test?
You may need a lung cancer genetic testing if you have been diagnosed with lung cancer. The test results may help your provider know which treatments are likely to help you the most and which ones may not help at all.
What happens during a lung cancer genetic test?
The best sample for lung cancer genetic tests is tissue from a tumor in your lung. The procedure to collect a tissue sample is called a biopsy. If you had a biopsy to diagnose your cancer, the same tissue may be used to test for gene changes.
There are several ways to do a lung biopsy. The type of biopsy you have depends on many things, including where the cancer is growing in your lungs. In certain cases, tissue may be removed with a special hollow needle inserted through your skin and into your lung.
A tissue sample may also be removed during a bronchoscopy or with a procedure that involves making an incision (cut) in your chest area to insert special tube-like instruments into your lung. Talk with your provider to find out which biopsy method will work for you.
If tumor tissue can't be collected, a blood test may be used for genetic testing in certain cases. Tumor cells shed DNA into your bloodstream. Testing the tumor DNA in your blood is called a "liquid biopsy." This test is not as accurate as tests that use tumor tissue. Researchers are still studying the use of liquid biopsies to test for certain gene changes.
Will I need to do anything to prepare for the test?
Ask your provider if you need to do anything to prepare for your test.
Are there any risks to the test?
If you have a biopsy, the risks depend on the type of procedure you have. In general, you may have a little bruising or bleeding at the biopsy site. You may also have some discomfort. Ask your provider about any risks involved with the test you're having.
What do the results mean?
If your lung cancer cells have a gene change that may respond well to a targeted therapy, your provider may start you on that treatment.
If your results show you don't have a gene change that matches a targeted therapy, your provider may discuss other treatment options. If you were tested for one gene change, other tests may be done to look for other gene changes that have targeted therapies.
Your test results may also show that your lung cancer has a gene change that:
- May prevent a certain therapy from working. This information could spare you from getting treatment that won't help.
- Doesn't help make treatment decisions. Researchers don't understand the importance of all the gene changes that are found in cancer.
Genetic testing may take longer than many other types of lab tests. So, you may not get your results for a few days to a week or more. If you have questions about your results, talk with your provider.
Learn more about laboratory tests, reference ranges, and understanding results.
References
- American Cancer Society [Internet]. Atlanta: American Cancer Society Inc.; c2022. Biomarker Tests and Cancer Treatment; [updated 2020 Mar; cited 2022 Sep 19]; [about 4 screens]. Available from: https://www.cancer.org/cancer/diagnosis-staging/tests/biomarker-tests.html
- American Cancer Society [Internet]. Atlanta: American Cancer Society Inc.; c2022. How Is a Biopsy Done?; [updated 2021 Oct; cited 2022 Sep 19]; [about 2 screens]. Available from: https://www.cancer.org/cancer/diagnosis-staging/tests/biopsy-and-cytology-tests/biopsy-types.html
- American Cancer Society [Internet]. Atlanta: American Cancer Society Inc.; c2022. How Targeted Therapies Are Used to Treat Cancer; [updated 2022 May; cited 2022 Sep 19]; [about 2 screens]. Available from: https://www.cancer.org/cancer/managing-cancer/treatment-types/targeted-therapy/what-is.html
- American Cancer Society [Internet]. Atlanta: American Cancer Society Inc.; c2022.What Causes Lung Cancer?; [updated 2019 Oct 1; cited 2022 Sept 18]; [about 3 screens]. Available from: https://www.cancer.org/cancer/lung-cancer/causes-risks-prevention/what-causes.html
- American Lung Association [Internet]. Chicago: American Lung Association; c2022. Lung Cancer Biomarker Testing; [updated 2021 Nov 16; cited 2022 Sep 19]; [about 9 screens]. Available from: https://www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/symptoms-diagnosis/biomarker-testing
- FDA: US Food and Drug Administration [Internet]. Silver Spring (MD): U.S. Department of Health and Human Services; FDA approves liquid biopsy NGS companion diagnostic test for multiple cancers and biomarkers; [current as of 2020 Nov 9; cited 2022 Sep 19]; [about 4 screens]. Available from: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-liquid-biopsy-ngs-companion-diagnostic-test-multiple-cancers-and-biomarkers
- Johns Hopkins Medicine [Internet]. The Johns Hopkins University; Johns Hopkins Medicine; Health Library: Lung Biopsy; [cited 2022 Sep 19]; [about 12 screens]. Available from: https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/lung-biopsy
- Mayo Clinic: Mayo Medical Laboratories [Internet]. Mayo Foundation for Medical Education and Research; c1995-2022. Test ID: MCLNM: MayoComplete Lung Cancer Mutations, Next-Generation Sequencing, Tumor: Clinical and Interpretive; [cited 2022 Sep 19]; [about 3 screens]. Available from: https://www.mayocliniclabs.com/test-catalog/overview/616487#Clinical-and-Interpretive
- MedlinePlus [Internet]. Bethesda (MD): National Library of Medicine (US); ALK gene; [updated 2011 Mar 1; cited 2022 Sep 19]; [about 2 screens]. Available from: https://medlineplus.gov/genetics/gene/alk/
- MedlinePlus [Internet]. Bethesda (MD): National Library of Medicine (US); EGFR gene; [updated 2017 Dec 1; cited 2022 Sep 19]; [about 4 screens]. Available from: https://medlineplus.gov/genetics/gene/egfr/
- MedlinePlus [Internet]. Bethesda (MD): National Library of Medicine (US); KRAS gene; [updated 2017 Dec 1; cited 2022 Sep 19]; [about 7 screens]. Available from: https://medlineplus.gov/genetics/gene/kras/
- MedlinePlus [Internet]. Bethesda (MD): National Library of Medicine (US); Lung Cancer; [updated 2017 Dec 1; cited 2022 Sep 19]; [about 8 screens]. Available from: https://medlineplus.gov/genetics/condition/lung-cancer/
- MedlinePlus [Internet]. Bethesda (MD): National Library of Medicine (US); What is a gene variant and how do variants occur?; [updated 2021 Mar 25; cited 2022 Sep 19]; [about 3 screens]. Available from: https://medlineplus.gov/genetics/understanding/mutationsanddisorders/genemutation/
- Merck Manual Consumer Version [Internet]. Kenilworth (NJ): Merck & Co. Inc.; c2022. Lung Cancer; [updated 2020 Jul; cited 2022 Sep 19]; [about 9 screens]. Available from: https://www.merckmanuals.com/home/lung-and-airway-disorders/tumors-of-the-lungs/lung-cancer
- National Cancer Institute [Internet]. Bethesda (MD): U.S. Department of Health and Human Services; Advances in Lung Cancer Research; [updated 2021 Oct 26; cited 2022 Sep 18]; [about 5 screens]. Available from: https://www.cancer.gov/types/lung/research
- National Cancer Institute [Internet]. Bethesda (MD): U.S. Department of Health and Human Services; Biomarker Testing for Cancer Treatment; [updated 2021 Dec 14; cited 2022 Sep 19]; [about 6 screen]. Available from: https://www.cancer.gov/about-cancer/treatment/types/biomarker-testing-cancer-treatment
- National Cancer Institute [Internet]. Bethesda (MD): U.S. Department of Health and Human Services; NCI Dictionary of Cancer Terms: gene; [cited 2022 Sep 19]; [about 1 screen]. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gene
- National Cancer Institute [Internet]. Bethesda (MD): U.S. Department of Health and Human Services; Non-Small Cell Lung Cancer Treatment (PDQ(r))-Patient Version; [updated 2021 Aug 27; cited 2022 Sep 19]; [about 44 screens]. Available from: https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq
- National Cancer Institute [Internet]. Bethesda (MD): U.S. Department of Health and Human Services; Tumor Markers; [updated 2021 May 11; cited 2022 Sep 19]; [about 5 screens]. Available from: https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/tumor-markers-fact-sheet
- Testing.com [Internet]. Seattle (WA): OneCare Media; c2022. ALK Mutation (Gene Rearrangement); [modified 2021 June 28; cited 2022 Sep 19]; [about 7 screens]. Available from: https://www.testing.com/tests/alk-mutation-gene-rearrangement/
- Testing.com [Internet]. Seattle (WA): OneCare Media; c2022. EGFR Mutation Testing; [modified 2020 Mar 6; cited 2022 Sep 19]; [about 10 screens]. Available from: https://www.testing.com/tests/egfr-mutation-testing/
- Testing.com [Internet]. Seattle (WA): OneCare Media; c2022. Genetic Tests for Targeted Cancer Therapy; [modified 2021 May 13; cited 2022 Sep 19]; [about 11 screens]. Available from: https://www.testing.com/tests/genetic-tests-targeted-cancer-therapy/
- Testing.com [Internet]. Seattle (WA): OneCare Media; c2022. KRAS Mutation; [modified 2019 Nov 15; cited 2022 Sep 19]; [about 8 screens]. Available from: https://www.testing.com/tests/kras-mutation/
- Testing.com [Internet]. Seattle (WA): OneCare Media; c2022. Tumor Markers; [modified 2021 Nov 9; cited 2022 Sep 19]; [about 12 screens]. Available from: https://www.testing.com/tests/tumor-markers/
The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.